Navigation Links
National Institute Of Health & Family Welfare To Commercialize Its Products

A Memorandum of Agreement was signed today between the National Institute of Health & Family Welfare (NIHFW) and National Research Development Corporation (NRDC) for transfer of technology developed by the NIHFW in the fields of Thermo Stable Elisa Kits and Laboratory Kits for Testing Sperm Functions. The up scaling of technologies developed by the Institute will be taken up by NRDC for commercialization. Prof. Deoki Nandan, Director, NIHFW and Mr. Somenath Ghosh, Chairman & Managing Director, NRDC signed the Memorandum of Agreement. This is the first time that the technology developed by NIHFW is being taken up for commercialization.

Thermo Stable Elisa Kits technology allows enzyme conjugate and antibody to retain their enzymatic and immunological activity respectively at 37oC for three months or more than two years at 2 to 8oC. The thermo stability technology for enzyme conjugate can have applicative value in those Elisa kits that are based on the use of enzyme horseradish peroxidase as label. The imported kits wherein horseradish peroxidase enzyme used are not thermo stable (can not with stand higher temperature of 37oC for more than twenty four hours). They require cold chain for their transport and storage. The new technologies are useful in production of Thermo-Stable Elisa Kits.

Three technological kits have been developed for testing Sperm functions. These will help to test many of the specialized functions of the sperms which otherwise are not routinely examined. It will strengthen the existing diagnostic tools in the male infertility diagnosis and management. It has the great potential to be routinely used in human sperm banks and can be extended in the same area for veterinary applications. At present no such laboratory kit for sperm function is available in the market. The kits do not require any imported material and have been developed indigenously.

In addition, the institute has also developed a vaginal co ntraceptives technology, which is water based, very much effective, less expansive and expected to provide wide acceptability.


'"/>




Related medicine news :

1. National Lung Study in the process
2. Indian Nationals with Foreign Medical Degrees can now practice in India
3. Hepatitis B Vaccine To Be Included In National Immunization Programme
4. UK Govt Says On Course For National Chlamydia Screening
5. Mexico and US border attain a new outlook due to BiNational Sustainability Laboratory
6. India extends National TB Control Program
7. President and Founder of National Obesity Forum Resigns
8. Hwang Woo Suk Suspended By Seoul National University
9. Indian National in Saudi Jail will be released soon
10. National Women and Girls HIV/AIDS Awareness Day
11. Calcutta National Medical College Strike Continues Unabated
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... ... 23, 2017 , ... Rare Disease Report®, which is the ... Rare Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) on ... weekly e-newsletter and quarterly publication, will be conducting interviews with patients and advocates ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, a ... content marketing, social media management, corporate communications, SEO and cause marketing, is opening ... in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding its ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing ... generations converge and explore the world from different perspectives. By providing a place ... to gain understanding, increase empathy, and find greater happiness. , "Our approach ...
(Date:2/23/2017)... RI (PRWEB) , ... February 23, 2017 , ... ... today a new partnership with the Rhode Island Consortium for Autism Research and ... an opportunity for children with autism spectrum disorder (ASD) to see films in ...
(Date:2/23/2017)... York (PRWEB) , ... February 23, 2017 , ... Curemark, ... the safety and efficacy of CM-AT in children aged 3-8 with Autism, is now ... clinical sites already enrolling children across the United States. , “There are currently ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Analysis and Strategies - 2016" report to their offering. ... The latest research ... pricing data and benchmarks in the global Oesophageal Cancer market. ... What are the key drugs marketed for Oesophageal Cancer and ...
(Date:2/23/2017)... 2017 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ... and commercialization of innovative therapies for the treatment ... release fourth quarter and yearly financial results after ... management will host an investment-community conference call at ... on March 2 nd 2017 to discuss ...
(Date:2/23/2017)... , February 23, 2017 ... from increasing caseload for varicose veins in their body. ... globe are prompting the adoption of endovenous laser therapy ... global endovenous laser therapy market, published by ... of lifestyle choices and consequences of obesity have collectively ...
Breaking Medicine Technology: